HK1: A Novel Antibiotic Candidate
The fight against antibiotic resistance is a global health imperative, driving the urgent need for novel therapeutic solutions. In this battlefield, HK1 has emerged as a promising candidate. This molecule exhibits potent activity against a broad spectrum of bacterial pathogens, including MDR strains that pose a significant threat to human health.